Applied DNA Sciences, Inc.
APDN
$5.37
-$0.14-2.54%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.36M | -8.53M | -6.99M | -7.29M | -12.27M |
| Total Depreciation and Amortization | 388.50K | 456.10K | 696.50K | 949.20K | 1.16M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -5.30M | -4.18M | -6.28M | -6.62M | -764.40K |
| Change in Net Operating Assets | -979.60K | -1.03M | -1.14M | -178.70K | 851.20K |
| Cash from Operations | -13.25M | -13.28M | -13.71M | -13.14M | -11.02M |
| Capital Expenditure | -695.30K | -524.80K | -407.90K | -961.30K | -1.10M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 0.00 | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -695.30K | -524.80K | -407.90K | -961.30K | -1.10M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 18.01M | 20.05M | 13.79M | 13.79M | 2.98M |
| Repurchase of Common Stock | -390.70K | -390.70K | -390.70K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 80.60K | 0.00 | 0.00 | 0.00 |
| Cash from Financing | 17.62M | 19.74M | 13.40M | 13.79M | 2.98M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.67M | 5.94M | -720.70K | -314.10K | -9.14M |